House Cuts Orphan Drug Credit in Half as Part of Tax Reform Bill

Drug Industry Daily
The House of Representatives moved closer to passing the final version of the Republicans’ tax reform legislation Tuesday, a sweeping $1.5 trillion measure that reduces or eliminates many deductions and credits — including cutting the orphan drug research tax credit in half.

To View This Article:


Subscribe To Drug Industry Daily